BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37877150)

  • 21. Two different genetic etiologies for tuberous sclerosis complex (TSC) in a single family.
    Mowrey K; Koenig MK; Szabo CA; Samuels J; Mulligan S; Pearson DA; Northrup H
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1296. PubMed ID: 32383331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel TSC2 c.3610G > A, p.G1204R mutation contribute to aberrant splicing in a patient with classical tuberous sclerosis complex: a case report.
    Zhang R; Wang J; Wang Q; Han Y; Liu X; Bottillo I; Lang Y; Shao L
    BMC Med Genet; 2018 Sep; 19(1):173. PubMed ID: 30236073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidental diagnosis of tuberous sclerosis complex by exome sequencing in three families with subclinical findings.
    Caylor RC; Grote L; Thiffault I; Farrow EG; Willig L; Soden S; Amudhavalli SM; Nopper AJ; Horii KA; Fleming E; Jenkins J; Welsh H; Ilyas M; Engleman K; Abdelmoity A; Saunders CJ
    Neurogenetics; 2018 Aug; 19(3):205-213. PubMed ID: 29926239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-level mosaicism in tuberous sclerosis complex in four unrelated patients: Comparison of clinical characteristics and diagnostic pathways.
    Manzanilla-Romero HH; Weis D; Schnaiter S; Rudnik-Schöneborn S
    Am J Med Genet A; 2021 Dec; 185(12):3851-3858. PubMed ID: 34328706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
    Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
    IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of neurodevelopmental abnormalities, congenital heart and renal defects in a tuberous sclerosis complex patient cohort.
    Robinson J; Uzun O; Loh NR; Harris IR; Woolley TE; Harwood AJ; Gardner JF; Syed YA
    BMC Med; 2022 Apr; 20(1):123. PubMed ID: 35440050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study.
    Ogórek B; Hamieh L; Hulshof HM; Lasseter K; Klonowska K; Kuijf H; Moavero R; Hertzberg C; Weschke B; Riney K; Feucht M; Scholl T; Krsek P; Nabbout R; Jansen AC; Benova B; Aronica E; Lagae L; Curatolo P; Borkowska J; Sadowski K; Domańska-Pakieła D; Janson S; Kozlowski P; Urbanska M; Jaworski J; Jozwiak S; Jansen FE; Kotulska K; ; Kwiatkowski DJ
    Genet Med; 2020 Sep; 22(9):1489-1497. PubMed ID: 32461669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a de novo TSC2 variant in a Han-Chinese family with tuberous sclerosis complex.
    Wu S; Guo Y; Liu C; Liu Q; Deng H; Yuan L
    J Chin Med Assoc; 2021 Jan; 84(1):46-50. PubMed ID: 33177398
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    He J; Zhou W; Shi J; Lin J; Zhang B; Sun Z
    Genet Test Mol Biomarkers; 2020 Jan; 24(1):1-5. PubMed ID: 31855466
    [No Abstract]   [Full Text] [Related]  

  • 30. The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions.
    Man A; Di Scipio M; Grewal S; Suk Y; Trinari E; Ejaz R; Whitney R
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel heterozygous TSC2 splicing variant in a patient with Tuberous sclerosis complex: A case report.
    Liu L; Yu C; Yan G
    Medicine (Baltimore); 2022 Jan; 101(3):e28666. PubMed ID: 35060563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
    MacKeigan JP; Krueger DA
    Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberous Sclerosis Complex in Chinese patients: Phenotypic analysis and mutational screening of TSC1/TSC2 genes.
    Lin S; Zeng JB; Zhao GX; Yang ZZ; Huang HP; Lin MT; Wu ZY; Wang N; Chen WJ; Fang L
    Seizure; 2019 Oct; 71():322-327. PubMed ID: 31525612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
    Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
    Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reprint of: lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas & renal cell carcinoma.
    Gupta S; Stanton ML; Reynolds JP; Whaley RD; Herrera-Hernandez L; Jimenez RE; Cheville JC
    Hum Pathol; 2023 Mar; 133():136-152. PubMed ID: 36894367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.
    Lee N; Woodrum CL; Nobil AM; Rauktys AE; Messina MP; Dabora SL
    BMC Pharmacol; 2009 Apr; 9():8. PubMed ID: 19368729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
    Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
    Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation landscape of TSC1/TSC2 in Chinese patients with tuberous sclerosis complex.
    Meng Y; Yu C; Chen M; Yu X; Sun M; Yan H; Zhao W; Yu S
    J Hum Genet; 2021 Mar; 66(3):227-236. PubMed ID: 32917966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital lymphedema as a rare and first symptom of tuberous sclerosis complex.
    Klinner J; Krüger M; Brunet T; Makowski C; Riedhammer KM; Mollweide A; Wagner M; Hoefele J
    Gene; 2020 Aug; 753():144815. PubMed ID: 32479982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic
    Lee WS; Macdonald-Laurs E; Stephenson S; D'Arcy C; Maixner W; Harvey AS; Lockhart PJ; Leventer RJ
    Neurology; 2023 Jul; 101(2):78-82. PubMed ID: 37015817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.